(Via ibtimes.co.uk) In the wake of recent Ebola diagnoses in Texas, many US biotech and medical firms enjoyed a sharp rise in value on the stock market. Particularly worthy of note is biotechnology company Ibio, whose shares closed up 66.67% at the end of trading.

Read the full story here.